Literature DB >> 18598189

Dengue in Vietnamese infants--results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity.

Tran Nguyen Bich Chau1, Nguyen Than Ha Quyen, Tran Thi Thuy, Nguyen Minh Tuan, Dang Minh Hoang, Nguyen Thi Phuong Dung, Le Bich Lien, Nguyen Thien Quy, Nguyen Trong Hieu, Lu Thi Minh Hieu, Tran Tinh Hien, Nguyen Thanh Hung, Jeremy Farrar, Cameron P Simmons.   

Abstract

The pathogenesis of severe dengue is not well understood. Maternally derived subneutralizing levels of dengue virus-reactive IgG are postulated to be a critical risk factor for severe dengue during infancy. In this study, we found that, in healthy Vietnamese infants, there was a strong temporal association between the Fc-dependent, dengue virus infection-enhancing activity of neat plasma and the age-related epidemiology of severe dengue. We then postulated that disease severity in infants with primary infections would be associated with a robust immune response, possibly as a consequence of higher viral burdens in vivo. Accordingly, in infants hospitalized with acute dengue, the activation phenotype of peripheral-blood NK cells and CD8+ and CD4+ T cells correlated with overall disease severity, but HLA-A*1101-restricted NS3(133-142)-specific CD8+ T cells were not measurable until early convalescence. Plasma levels of cytokines/chemokines were generally higher in infants with dengue shock syndrome. Collectively, these data support a model of dengue pathogenesis in infants whereby antibody-dependent enhancement of infection explains the age-related case epidemiology and could account for antigen-driven immune activation and its association with disease severity. These results also highlight potential risks in the use of live attenuated dengue vaccines in infants in countries where dengue is endemic.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598189      PMCID: PMC2730540          DOI: 10.1086/590117

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

Review 1.  Dengue: an update.

Authors:  María G Guzmán; Gustavo Kourí
Journal:  Lancet Infect Dis       Date:  2002-01       Impact factor: 25.071

2.  Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.

Authors:  Daniel H Libraty; Timothy P Endy; Huo-Shu H Houng; Sharone Green; Siripen Kalayanarooj; Saroj Suntayakorn; Wanya Chansiriwongs; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

3.  Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever.

Authors:  E L Azeredo; S M Zagne; M A Santiago; A S Gouvea; A A Santana; P C Neves-Souza; R M Nogueira; M P Miagostovich; C F Kubelka
Journal:  Immunobiology       Date:  2001-12       Impact factor: 3.144

4.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.

Authors:  D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; T P Endy; B Raengsakulrach; A L Rothman; F A Ennis; A Nisalak
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

5.  Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles.

Authors:  Thanh Hung Nguyen; Huan-Yao Lei; Trong Lan Nguyen; Yee-Shin Lin; Kao-Jean Huang; Bich Lien Le; Chiou-Feng Lin; Trai-Ming Yeh; Quang Ha Do; Thi Que Huong Vu; Lien-Cheng Chen; Jyh-Hsiung Huang; Thi My Lam; Ching-Chuan Liu; Scott B Halstead
Journal:  J Infect Dis       Date:  2004-01-09       Impact factor: 5.226

6.  Maternal antibody and viral factors in the pathogenesis of dengue virus in infants.

Authors:  Cameron P Simmons; Tran Nguyen Bich Chau; Tran Thi Thuy; Nguyen Minh Tuan; Dang Minh Hoang; Nguyen Thanh Thien; Le Bich Lien; Nguyen Thien Quy; Nguyen Trong Hieu; Tran Tinh Hien; Catriona McElnea; Paul Young; Steve Whitehead; Nguyen Thanh Hung; Jeremy Farrar
Journal:  J Infect Dis       Date:  2007-06-19       Impact factor: 5.226

7.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak.

Authors:  N Sangkawibha; S Rojanasuphot; S Ahandrik; S Viriyapongse; S Jatanasen; V Salitul; B Phanthumachinda; S B Halstead
Journal:  Am J Epidemiol       Date:  1984-11       Impact factor: 4.897

8.  Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.

Authors:  Juthathip Mongkolsapaya; Wanwisa Dejnirattisai; Xiao-ning Xu; Sirijitt Vasanawathana; Nattaya Tangthawornchaikul; Aroonrung Chairunsri; Siraporn Sawasdivorn; Thaneeya Duangchinda; Tao Dong; Sarah Rowland-Jones; Pa-thai Yenchitsomanus; Andrew McMichael; Prida Malasit; Gavin Screaton
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

9.  Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses.

Authors:  Mary Jane Cardosa; Seok Mui Wang; Magdline Sia H Sum; Phaik Hooi Tio
Journal:  BMC Microbiol       Date:  2002-05-05       Impact factor: 3.605

Review 10.  Dengue hemorrhagic fever in infants: research opportunities ignored.

Authors:  Scott B Halstead; Nguyen Trong Lan; Thein Thein Myint; Than Nu Shwe; Ananda Nisalak; Siripen Kalyanarooj; Suchitra Nimmannitya; Soegeng Soegijanto; David W Vaughn; Timothy P Endy
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more
  84 in total

Review 1.  Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials.

Authors:  Aravinda M de Silva; Eva Harris
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

2.  Protection by immunoglobulin dual-affinity retargeting antibodies against dengue virus.

Authors:  James D Brien; Soila Sukupolvi-Petty; Katherine L Williams; Chia-Ying Kao Lam; Michael A Schmid; Syd Johnson; Eva Harris; Michael S Diamond
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

3.  Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants.

Authors:  Priscila M S Castanha; Cynthia Braga; Marli T Cordeiro; Ariani I Souza; Claudeir D Silva; Celina M T Martelli; Willem G van Panhuis; Eduardo J M Nascimento; Ernesto T A Marques
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

Review 4.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 5.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

6.  Dengue viruses cluster antigenically but not as discrete serotypes.

Authors:  Leah C Katzelnick; Judith M Fonville; Gregory D Gromowski; Jose Bustos Arriaga; Angela Green; Sarah L James; Louis Lau; Magelda Montoya; Chunling Wang; Laura A VanBlargan; Colin A Russell; Hlaing Myat Thu; Theodore C Pierson; Philippe Buchy; John G Aaskov; Jorge L Muñoz-Jordán; Nikos Vasilakis; Robert V Gibbons; Robert B Tesh; Albert D M E Osterhaus; Ron A M Fouchier; Anna Durbin; Cameron P Simmons; Edward C Holmes; Eva Harris; Stephen S Whitehead; Derek J Smith
Journal:  Science       Date:  2015-09-18       Impact factor: 47.728

7.  Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.

Authors:  Erin Mehlhop; Steevenson Nelson; Christiane A Jost; Sergey Gorlatov; Syd Johnson; Daved H Fremont; Michael S Diamond; Theodore C Pierson
Journal:  Cell Host Microbe       Date:  2009-10-22       Impact factor: 21.023

8.  Clinical and virological features of Dengue in Vietnamese infants.

Authors:  Tran Nguyen Bich Chau; Katherine L Anders; Le Bich Lien; Nguyen Thanh Hung; Lu Thi Minh Hieu; Nguyen Minh Tuan; Tran Thi Thuy; Le Thi Phuong; Nguyen Thi Hong Tham; Mai Ngoc Lanh; Jeremy J Farrar; Stephen S Whitehead; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2010-04-13

9.  Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification.

Authors:  Scott J Balsitis; Katherine L Williams; Ruben Lachica; Diana Flores; Jennifer L Kyle; Erin Mehlhop; Syd Johnson; Michael S Diamond; P Robert Beatty; Eva Harris
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

10.  A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.

Authors:  Daniel H Libraty; Luz P Acosta; Veronica Tallo; Edelwisa Segubre-Mercado; Analisa Bautista; James A Potts; Richard G Jarman; In-Kyu Yoon; Robert V Gibbons; Job D Brion; Rosario Z Capeding
Journal:  PLoS Med       Date:  2009-10-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.